Total Funding
33
27
Total FundingPrivate Equity raised
Growth Score 33 in past quarter
-2 pts
Heat Score 27 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
83542
A privately funded clinical stage company based Massachusetts .
- Mark Corrigan: Co-Founder & President of research and development
About the Company
Tremeau Pharmaceuticals is a Massachusetts based privately funded clinical stage company focused on commercializing non-opioid pain therapies targeting serious rare diseases impacted by the cyclooxygenase (COX) or prostanoid pathways.
They focus exclusively on orphan or unique disease states with high unmet medical need.